|
Apr 25
|
Cancer drugs help drive AstraZeneca sales sharply higher
|
|
Apr 25
|
AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
|
Apr 25
|
Trending tickers: Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's
|
|
Apr 25
|
AstraZeneca Earnings, Sales Rise, Beat Forecasts
|
|
Apr 25
|
UPDATE 2-AstraZeneca trounces first-quarter estimates as resilient demand fuels growth
|
|
Apr 25
|
AstraZeneca leaps after smashing first-quarter forecasts
|
|
Apr 25
|
Q1 2024 results
|
|
Apr 24
|
Alphabet, Microsoft, Southwest earnings: What to watch
|
|
Apr 23
|
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
|
|
Apr 22
|
With 85% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backing
|
|
Apr 22
|
Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics
|
|
Apr 21
|
11 Best Low Price Pharma Stocks To Invest In
|
|
Apr 19
|
20 Countries with the Highest Cancer Survival Rates in the World
|
|
Apr 18
|
Astrazeneca (AZN) Could Be a Great Choice
|
|
Apr 16
|
IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial
|
|
Apr 14
|
4 Exceptional Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
|
|
Apr 12
|
AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids
|
|
Apr 12
|
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
|
|
Apr 11
|
Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know
|
|
Apr 11
|
AstraZeneca hit by investor backlash over chief Pascal Soriot’s £19m pay deal
|